Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Signifi

Altimmune has a modest market cap but an incredibly promising GLP-1 drug.... Read more

Bron:

Fool.com: The Motley Fool